Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.45 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.45 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.45 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | PYGB | P11216 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27170348 | 1.00 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL20610479 | 1.00 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL7109528 | 1.00 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL27170351 | 1.00 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL2493227 | 1.00 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL28106543 | 1.00 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL13955988 | 0.85 | LGALS1 (0.47) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL19975699 | 0.85 | LGALS1 (0.33) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL16837353 | 0.85 | LGALS1 (0.47) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL13955989 | 0.85 | LGALS1 (0.47) | LGALS1LGALS3LGALS9LGALS8PYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4171487-A1 | COSMETIC COMPOSITION FOR IMPROVED PENETRATION | L'OREAL (FR) | 2023-05-03 | — | — | EP | claimed |
| CN-110366408-B | Cosmetic composition comprising one or more polar oils, a C2-C6 aliphatic monohydric and polyhydric alcohol, at least one hydrophilic active agent, and comprising less than 7% by weight of water | 莱雅公司 | 2023-05-02 | — | — | CN | claimed |
| WO-2022006047-A1 | COSMETIC COMPOSITION FOR IMPROVED PENETRATION | L'OREAL (FR) | 2022-01-06 | — | — | WO | claimed |
| US-20210401715-A1 | COSMETIC COMPOSITION FOR IMPROVED PENETRATION | L'OREAL (FR) | 2021-12-30 | — | — | US | claimed |
| CN-110366408-A | It comprising one or more polar oils, the pure and mild polyalcohol of C2-C6 aliphatic mono, at least one hydrophilic active agent, and include the cosmetic composition of the water by weight less than 7% | 莱雅公司 | 2019-10-22 | — | — | CN | claimed |
| US-9421157-B2 | Use of C-glycoside derivatives as pro-desquamating active agents | L'OREAL (FR) | 2016-08-23 | — | — | US | claimed |
| EP-2206491-B1 | Association of monosaccharides and C-glycoside derivatives and its use in cosmetics | ORÉAL L (FR) | 2016-08-17 | — | — | EP | claimed |
| US-7862804-B2 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | LOREAL (FR) | 2011-01-04 | — | — | US | claimed |
| US-20100190742-A1 | COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISING HYALURONIC ACID AND ADMINISTRATION THEREOF FOR REDUCING SIGNS OF AGING | L'OREAL (FR) | 2010-07-29 | — | — | US | claimed |
| EP-2206491-A1 | Association of monosaccharides and C-glycoside derivatives and its use in cosmetics | L'OREAL (FR) | 2010-07-14 | — | — | EP | claimed |
| US-20080003191-A1 | Composition combining a C-glycoside derivative and an emulsifying polymer | L'OREAL (FR) | 2008-01-03 | — | — | US | claimed |
| EP-1853217-A1 | HAIRCARE USE OF C-GLYCOSIDE DERIVATIVES | L'Oréal (FR) | 2007-11-14 | — | — | EP | claimed |
| CN-1965784-A | Use of C-glycosides for depigmenting skin | OREAL (FR) | 2007-05-23 | — | — | CN | claimed |
| EP-1774990-A1 | Use of c-glycosides for depigmenting skin | L'Oréal (FR) | 2007-04-18 | — | — | EP | claimed |
| US-20070081956-A1 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | L'OREAL (FR) | 2007-04-12 | — | — | US | claimed |
| WO-2006090307-A1 | HAIRCARE USE OF C-GLYCOSIDE DERIVATIVES | L'OREAL (FR) | 2006-08-31 | — | — | WO | claimed |
| US-7049300-B2 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | L'OREAL (FR) | 2006-05-23 | — | — | US | claimed |
| US-20040048785-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | SOCIETE L'OREAL S.A. (FR) | 2004-03-11 | — | — | US | claimed |
| EP-1345919-A2 | NOVEL C-GLYCOSIDE DERIVATIVES AND USE THEREOF | L'OREAL (FR) | 2003-09-24 | — | — | EP | claimed |
| WO-2002051828-A2 | NOVEL C-GLYCOSIDE DERIVATIVES AND USE THEREOF | L'OREAL (FR) | 2002-07-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210401715-A1 | COSMETIC COMPOSITION FOR IMPROVED PENETRATION | UGCG, DSG1, DDOST | LGALS1 114/4885LGALS3 79/4885LGALS9 223/4885 |
| US-20070081956-A1 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | TYR, CAT, NQO1 | LGALS1 640/4885LGALS3 554/4885LGALS9 1197/4885 |
| US-20100190742-A1 | COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISING HYALURONIC ACID AND ADMINISTRATION THEREOF FOR REDUCING SIGNS OF AGING | GLA, CD44, FUT6 | LGALS1 88/4885LGALS3 81/4885LGALS9 235/4885 |
| US-20040048785-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | CSGALNACT1, FUT6, AREG | LGALS1 182/4885LGALS3 124/4885LGALS9 239/4885 |
| US-20080003191-A1 | Composition combining a C-glycoside derivative and an emulsifying polymer | CUTA, UGCG, PSAP | LGALS1 154/4885LGALS3 98/4885LGALS9 431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.